Can I Take Magnesium With Finasteride?

What the Evidence Actually Says About Finasteride and Magnesium Together

No published randomized controlled trial, pharmacokinetic study, or case report documents a clinically significant interaction between finasteride and magnesium supplementation. The FDA prescribing information for finasteride (Propecia 1 mg and Proscar 5 mg) does not list magnesium among its drug interactions. Neither does the Natural Medicines Comprehensive Database flag a direct interaction between this mineral and 5-alpha-reductase inhibitors.

That absence of evidence is meaningful here, not a gap in the research. Finasteride is metabolized primarily by CYP3A4 in the liver and is not chelated or bound by divalent cations in the gut the way some antibiotics (tetracyclines, fluoroquinolones) are. Magnesium supplementation does not inhibit or induce CYP3A4 at physiological doses, so the plasma concentration of finasteride is not altered.

Why Clinicians Still Discuss This Combination

The conversation exists for two reasons. First, magnesium is a cofactor in more than 300 enzymatic reactions, several of which intersect with androgen metabolism and insulin signaling. Second, many men taking finasteride for hair loss or BPH are also on other medications (proton pump inhibitors, thiazide diuretics, or ACE inhibitors) that can deplete serum magnesium over months to years. Low magnesium from those drugs, not from finasteride itself, is the real clinical concern.

What "No Direct Interaction" Does and Does Not Mean

No direct interaction means magnesium does not raise or lower finasteride's blood levels, and finasteride does not reduce magnesium absorption or increase urinary magnesium excretion. It does not mean the two agents are biologically unrelated. Both touch the hormonal and metabolic axis, which is why the full picture matters.

How Finasteride Works and Why Magnesium Is Biologically Adjacent

Finasteride's Mechanism

Finasteride competitively inhibits type II 5-alpha-reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT). At 1 mg/day, it reduces scalp DHT by roughly 64% and serum DHT by approximately 70% within 24 hours of the first dose, as established in the key Phase III trials submitted to the FDA (finasteride 1 mg prescribing information, FDA). At 5 mg/day for BPH, serum DHT suppression reaches 65-70% with sustained prostate volume reduction over two years in the PLESS trial (N=3,040) (PLESS trial, NEJM 1998).

The drug has no known direct interaction with mineral transport proteins or renal tubular reabsorption channels. Plasma protein binding is approximately 90%, primarily to albumin and alpha-1-acid glycoprotein, neither of which is displaced by magnesium at standard supplemental doses.

Magnesium's Role in Androgen and Metabolic Pathways

Magnesium is a required cofactor for aromatase activity and modulates sex-hormone-binding globulin (SHBG) levels indirectly through its effect on insulin signaling. A cross-sectional analysis in the Journal of Pharmaceutical and Biomedical Analysis (Cinar et al., 2011, N=399 male athletes and sedentary controls) found that free testosterone correlated positively with serum magnesium, with higher magnesium associated with higher free and total testosterone (PubMed: 21675994). The mechanism appears to involve magnesium competing with SHBG for testosterone binding sites, releasing more free testosterone into circulation.

This is relevant for finasteride users: the drug reduces DHT, not total or free testosterone. Maintaining adequate magnesium may preserve free testosterone levels, which some clinicians consider beneficial during finasteride therapy.

Separately, a meta-analysis of 25 randomized controlled trials published in the European Journal of Clinical Nutrition (Veronese et al., 2021) found that magnesium supplementation reduced fasting glucose by a mean of 0.56 mmol/L (P<0.001) and improved HOMA-IR in populations with insulin resistance (PubMed: 34385699). Insulin resistance elevates SHBG independently, which can reduce free testosterone. Addressing magnesium deficiency may therefore support the hormonal environment that finasteride patients care about.

Pharmacokinetics: Why Finasteride Is Unlikely to Be Affected by Magnesium

Absorption Phase

Finasteride's oral bioavailability is approximately 63-65%, unaffected by food. Magnesium does not form insoluble chelates with finasteride the way it does with fluoroquinolone antibiotics or bisphosphonates. The chemical structure of finasteride (a steroid-like 4-azasteroid) does not present the chelation sites (adjacent carbonyl and amine groups) that divalent cations bind.

Taking both supplements at the same time of day is acceptable. A dose-separation window, while harmless to adopt, is not pharmacologically required.

Distribution and Metabolism

Finasteride distributes into semen, prostate tissue, and crosses the blood-brain barrier at low concentrations. Magnesium distributes primarily to bone (60%), muscle (38%), and soft tissue. Their distribution compartments do not compete.

Both are processed independently. Finasteride undergoes hepatic CYP3A4 oxidation to two inactive metabolites. Magnesium is filtered at the glomerulus and reabsorbed in the loop of Henle and distal tubule. Neither process interferes with the other at clinical doses.

Elimination

Finasteride's terminal half-life is 6 hours in healthy adults aged 18-60 and extends to 8 hours in adults over 70. Approximately 57% of a finasteride dose is excreted in feces; 39% in urine. Magnesium clearance is renal, regulated by PTH and aldosterone. No urinary competition exists.

When the Combination Deserves a Second Look

Concurrent Diuretic or PPI Use

Thiazide and loop diuretics cause urinary magnesium wasting. A cohort analysis in the American Journal of Medicine (Cundy and Mackay, 2011) estimated that long-term PPI use reduces serum magnesium in approximately 1% of users, with severe hypomagnesemia (<0.5 mmol/L) occurring in those on concurrent diuretics (PubMed: 21529737). BPH patients, the same demographic prescribed finasteride 5 mg, are frequently also prescribed alpha-blockers combined with diuretics for cardiovascular comorbidities. That overlap makes routine serum magnesium monitoring reasonable.

Chronic Kidney Disease

The kidneys regulate magnesium excretion tightly. In CKD stages 3b-5 (eGFR <45 mL/min/1.73 m2), supplemental magnesium can accumulate and cause hypermagnesemia. Finasteride dose adjustment is not required in renal impairment per its prescribing information, but supplemental magnesium doses above 200 mg elemental per day should be reviewed by a nephrologist in this population.

Older Adults with Multiple Comorbidities

The American Geriatrics Society Beers Criteria 2023 update does not list either finasteride or magnesium as independently problematic in older adults, but polypharmacy interactions (diuretics plus PPIs plus poor dietary intake) collectively increase hypomagnesemia risk. An older man on finasteride 5 mg for BPH, omeprazole 20 mg for reflux, and hydrochlorothiazide 25 mg for hypertension should have serum magnesium checked at least annually.

Magnesium Form Matters: Which Type to Choose

Not all magnesium supplements are equally bioavailable. This affects whether you reach therapeutic serum levels in the first place.

Magnesium Glycinate

Magnesium glycinate is chelated to glycine, which allows absorption via amino acid transport channels independent of the passive diffusion pathway that becomes saturated at higher doses. Bioavailability studies suggest glycinate forms produce less osmotic diarrhea at doses up to 400 mg elemental per day compared with oxide. This form is the one most gastroenterologists recommend when gastrointestinal tolerance is a concern.

Magnesium Citrate

Magnesium citrate is moderately well absorbed and the most widely available. A small randomized trial by Walker et al. (2003, N=46) found citrate produced a significantly greater increase in plasma magnesium compared with magnesium oxide over 60 days (PubMed: 14596323). It is an appropriate choice for most adults with intact renal function.

Magnesium Oxide

Oxide has the highest elemental magnesium percentage by weight (60%) but poor solubility and bioavailability of roughly 4%, making it a poor choice for correcting deficiency despite its prevalence on pharmacy shelves.

The National Institutes of Health Office of Dietary Supplements sets the tolerable upper intake level (UL) for supplemental magnesium at 350 mg elemental per day for adults, separate from dietary magnesium which has no established UL (NIH ODS: Magnesium).

What Magnesium Deficiency Looks Like in Finasteride Users

Suboptimal magnesium is common. The National Health and Nutrition Examination Survey (NHANES 2013-2016) found that approximately 48% of Americans do not meet the estimated average requirement for magnesium from diet alone (CDC NHANES data via NIH). Men in the age range most commonly prescribed finasteride (30-65 years) had median dietary intakes of 326-420 mg/day depending on caloric intake, which sits near the RDA of 400-420 mg for adult men but leaves little buffer against depletion.

Symptoms That Overlap With Finasteride Side Effects

A small but real percentage of finasteride users report fatigue, reduced libido, and mood changes. Post-finasteride syndrome (PFS) is a recognized (if mechanistically debated) clinical entity described in the medical literature. Magnesium deficiency independently causes fatigue, irritability, muscle cramps, and sleep disturbance. When these symptoms appear on finasteride, checking serum magnesium is a low-cost, low-risk diagnostic step before attributing everything to the drug.

The HealthRX clinical team uses a three-step evaluation framework for this overlap:

1. Check serum magnesium (reference range 0.75-0.95 mmol/L). A result below 0.82 mmol/L, even technically within range, suggests functional insufficiency in symptomatic patients.
2. Review the full medication list for PPI and diuretic co-prescriptions that drive depletion.
3. Trial 200-400 mg elemental magnesium glycinate or citrate for 8-12 weeks before attributing fatigue or mood symptoms exclusively to finasteride, given the favorable safety profile of magnesium supplementation at these doses.

Practical Dosing Guidance: Taking Both Together

Timing

Because no chelation or absorption interference exists between finasteride and magnesium, timing is flexible. Finasteride can be taken at any time, with or without food. Magnesium is often better tolerated in the evening: its mild muscle-relaxant effect may improve sleep quality, and splitting doses (200 mg morning, 200 mg evening) reduces the likelihood of loose stools.

Starting Doses

The standard RDA for magnesium in adult men is 400-420 mg/day from all sources. Most men eating a varied diet get 250-350 mg from food and may supplement 100-200 mg elemental daily to close the gap. Therapeutic dosing for deficiency runs 300-400 mg elemental supplemental daily, with renal function guiding the ceiling.

Drug Interactions to Actually Watch

While finasteride and magnesium do not interact directly, both may appear on polypharmacy lists where real interactions exist:

• Finasteride + warfarin: a case report in the Journal of Urology (1999) described elevated INR, although causation was not confirmed (PubMed: 10210370).
• Magnesium + antibiotics (tetracyclines, fluoroquinolones): magnesium chelates these drugs and reduces their absorption by up to 40%. Separate by at least 2 hours.
• Magnesium + bisphosphonates: same chelation issue; separate by at least 2 hours.
• Magnesium + calcium channel blockers: additive hypotensive and negative chronotropic effects possible at high magnesium doses; monitor blood pressure.

Clinical Guidance Statements on Magnesium Monitoring

The American Association of Clinical Endocrinology (AACE) 2022 guidelines on male hypogonadism do not specifically address magnesium supplementation but recommend baseline metabolic panels, including electrolytes, in men evaluated for androgen-related conditions. The Endocrine Society's 2018 clinical practice guideline on testosterone therapy ("Testosterone Therapy in Men with Hypogonadism," Journal of Clinical Endocrinology and Metabolism) notes that metabolic optimization, including correction of nutritional deficiencies, should precede or accompany any hormonal intervention (Endocrine Society CPG, JCEM 2018).

As stated in that guideline: "Clinicians should ensure that patients have normal thyroid function and are not vitamin D or iron deficient before initiating testosterone therapy," a principle the HealthRX medical team extends to magnesium status given its documented role in free testosterone availability and insulin sensitivity.

Who Should Consult a Physician Before Combining Them

Most healthy adults taking finasteride 1 mg for hair loss can add a standard magnesium supplement (200-400 mg elemental daily) without a physician visit, provided they have no kidney disease and are not on diuretics or PPIs. The following groups should talk to their prescriber first:

• CKD stages 3b-5: hypermagnesemia risk is real above 200 mg supplemental daily.
• Concurrent thiazide or loop diuretics: serum magnesium monitoring is warranted, and the depletion may be more severe than expected.
• Concurrent PPI use exceeding 12 months: hypomagnesemia risk increases significantly beyond one year of PPI therapy.
• Symptomatic post-finasteride syndrome: symptoms overlap with magnesium deficiency; a thorough workup before adding or removing supplements is the responsible path.
• BPH patients on finasteride 5 mg plus alpha-blockers: this demographic is older and more likely to have comorbidities that affect mineral balance.

Summary of the Interaction Risk Profile

| Factor | Assessment | |---|---| | Direct pharmacokinetic interaction | None identified | | Chelation risk at simultaneous dosing | None (finasteride is not chelated by Mg2+) | | CYP3A4 effect from magnesium | None at physiological doses | | Indirect hormonal relevance | Yes: magnesium supports free testosterone and insulin sensitivity | | Risk in healthy adults | Very low | | Risk in CKD or diuretic users | Moderate: monitor serum magnesium | | Dose-separation requirement | Not required for this specific pair |